In this article (Clin Cancer Res 2011;17:2301–13), which was published in the April 15, 2011 issue of Clinical Cancer Research (1), the following funding support is not included: Pacific Northwest Prostate SPORE NCI CA097186.
References
1.
Lamoureux
F
, Thomas
C
, Yin
M-J
, Kuruma
H
, Fazli
L
, Gleave
ME
, et al A novel HSP90 inhibitor delays castrate-resistant prostate cancer without altering serum PSA levels and inhibits osteoclastogenesis
. Clin Cancer Res
2011
;17
:2301
–13
.©2011 American Association for Cancer Research.
2011
RSS Feeds